Press release
Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation
Zurich, Switzerland, 1st Dec 2025 - Santersus AG today announced the successful completion of its Series A financing, led by Norcliffe, a UK life sciences fund with participation from Terumo Ventures. The financing will support the advancement of Santersus' NucleoCapture into pivotal clinical development while accelerating progress across Santersus' broader pipeline.
Santersus has entered a strategic collaboration with Terumo Blood and Cell Technologies to advance NucleoCapture(TM) for the treatment of sepsis, a disease that kills 11M people worldwide each year. The collaboration integrates Santersus' first-in-class NucleoCapture blood purification device with Terumo BCT's industry-leading Spectra Optia Apheresis System, creating a novel therapeutic apheresis approach designed to selectively remove neutrophil extracellular traps (NETs)-- a major contributor to systemic inflammation and sepsis-related organ dysfunction. NucleoCapture has previously been granted two U.S. FDA Breakthrough Device Designations, including one for the treatment of sepsis.
Under this collaboration, Santersus will lead the pivotal NUC-CAP clinical trial across the United States, United Kingdom, Switzerland and Europe. Terumo BCT will support the clinical development of the program, and Terumo Ventures - the corporate VC arm of Terumo - has invested in Santersus' Series A financing round to accelerate the development of this technology for a critical unmet need with high mortality.
"Therapeutic apheresis has untapped potential to address serious unmet medical needs," said Veerle d'Haenens, General Manager of Global Therapy Innovations at Terumo Blood and Cell Technologies. "Our partnership with Santersus reflects our commitment to advancing innovative treatment options for critically ill patients."
The Series A financing will also support Santersus' preparation for pivotal clinical trials in systemic lupus erythematosus (SLE), where NucleoCapture has received its second U.S. FDA Breakthrough Device Designation for treatment-refractory disease. The pivotal SLE program addressing an estimated $4bn global treatment market - will expand Santersus' late-stage clinical portfolio beyond critical care and is expected to begin following the sepsis study launch.
Santersus is also advancing NucleoCapture technology into solid-organ transplantation, including a program designed to perfuse and recondition heavily damaged donor livers prior to transplantation. The global organ transplantation market is projected to reach $61.5bn by 2027. In parallel, Santersus is expanding a NucleoCapture program in lung transplantation focused on the prevention of primary graft dysfunction (PGD). Together, these initiatives support the application of NucleoCapture across solid-organ transplantation.
Santersus is also advancing early-stage development of NucleoCapture for Alzheimer's disease, with an exploratory clinical study under way to assess its effects on amyloid removal. The global Alzheimer's therapeutics market is valued at approximately $5bn in 2025 and is projected to double over the next decade.
These integrated programs reflect Santersus' transition towards a multi-indication, late-stage clinical development company and position Santersus as a leading developer of NETs-targeted therapeutic apheresis technologies across critical care, autoimmunity, solid-organ transplantation, and neurodegeneration.
About Santersus AG
Zurich-based Santersus AG is a biotechnology company developing NucleoCapture, a novel, patent-protected extracorporeal blood purification technology designed to selectively remove cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs). NucleoCapture has received two U.S. FDA Breakthrough Device Designations: one for the treatment of sepsis and one for systemic lupus erythematosus. Santersus is advancing a diversified clinical pipeline across sepsis, systemic lupus erythematosus, solid-organ transplantation (liver and lung), and Alzheimer's disease.
For more information, please visit www.santersus.com
Contact Details
Organization: Santersus AG
Contact Person: Aleksander Zaporoztsev
Website: https://www.santersus.com
Email: info@santersus.com
Country: Switzerland
Release Id: 01122538172
The post Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation appeared first on King Newswire. This content is provided by a third-party source. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the 'Media Contact' section above.
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. king Newswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact support@kingnewswire.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation here
News-ID: 4295221 • Views: …
More Releases from King Newswire
Gastro Center of Maryland Expands Footprint, Bringing Expert Digestive Care to M …
Gastro Center of Maryland (GCM), one of the state's largest GI practices, announces expansion to serve more patients across the DMV. With locations in Annapolis, Bethesda, Columbia, Gaithersburg, Olney, Riverdale, Silver Spring, Timonium, and White Marsh, GCM offers comprehensive digestive care including colonoscopies, endoscopies, and advanced treatments. State-of-the-art facilities feature onsite pathology and an IBD Infusion Center. Same-week and NextDay appointments available. Now welcoming new patients.
Silver Spring, Maryland, United States,…
New Digital Philanthropy Initiative Launched at Asia Philanthropy Forum in Boao
In a significant move to harness technology for social good, the ECI@Charity Digital Philanthropy Innovation Committee was officially launched today at the Asia Philanthropy Forum in Boao. The establishment of this global platform marks a strategic evolution for ECI, positioning it from an innovation observer to a proactive builder in the philanthropic sector, leveraging the unique opportunities presented by the Hainan Free Trade Port.
Under the theme "Open Collaboration, Innovative Development,"…
VITAKING Launches Global Digital Gold Initiative in Los Angeles, Backed by 200+ …
U.S.-based fintech firm partners with global mining funds to build a decentralized RWA ecosystem anchored by real gold reserves.
VITAKING TECH LTD. announced the development of a new technology initiative focused on connecting traditional resource data with digital asset infrastructure. The project explores how emerging blockchain applications may support more efficient documentation, tracking, and management of physical-asset information through standardized digital systems.
VITAKING TECH LTD., a U.S.-registered technology company working in the…
Beyond Key Adds AI and Copilot Features to Microsoft Dynamics 365 for Smarter Bu …
Beyond Key has introduced advanced AI and Copilot features across Microsoft Dynamics 365 applications, including Sales, Customer Service, Marketing, and Business Central. This enhancement helps organizations automate manual tasks, improve decision-making, and deliver better customer experiences. With deep expertise in Microsoft technologies, Beyond Key ensures secure, seamless integration and provides guidance on licensing, data management, system customization, and AI readiness. These upgrades empower businesses to work smarter, streamline operations, and…
More Releases for Santersus
Future of the Blood Purification Equipment Market: Trends, Innovations, and Key …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Blood Purification Equipment Market Size Growth Forecast: What to Expect by 2025?
The market for blood purification equipment has seen robust growth in recent years. The market value, which stood at $20.71 billion in 2024, is poised to increase to $21.81 billion in 2025, implying a compound annual growth…
Blood Purification Equipment Market Insights 2025-2034: Growth Forecast and Stra …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Blood Purification Equipment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the market size of blood purification equipment has experienced significant growth. It is projected to expand from $20.71 billion in 2024 to $21.98 billion in 2025, boasting a compound annual growth rate (CAGR) of…
Strong Growth Ahead: Blood Purification Equipment Market Size To Grow At Arecord …
The Blood Purification Equipment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Blood Purification Equipment Market Size Expected to Be by 2034?
The market for blood purification equipment has seen robust growth in the past few years. The estimated value is expected…
Blood Purification Equipment Market Analysis, Top Drivers, Key Players, Segmenta …
"The new report published by The Business Research Company, titled ""Blood Purification Equipment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the blood purification equipment market size has grown strongly in recent years. It will grow from $19.9 billion…
Blood Purification Equipment Global Market Report 2024 - By Growth, Trends, Size …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Blood Purification Equipment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $28.71 billion In 2028…
Blood Purification Equipment Market 2024-2033: Trends, Analysis & Growth Forecas …
The blood purification equipment market size has grown strongly in recent years. It will grow from $19.9 billion in 2023 to $21.28 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increased renal diseases, aging population, government initiatives, growing icu admissions, rising chronic conditions..
The blood purification equipment market size is expected to see strong growth…
